Best Heal Care Stocks To Own For 2019


Zumiez (NASDAQ:ZUMZ) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

Several other equities research analysts have also recently weighed in on the company. Pivotal Research upgraded Zumiez from a “hold” rating to a “buy” rating and increased their price objective for the stock from $30.00 to $36.00 in a report on Tuesday, September 4th. BidaskClub upgraded Zumiez from a “hold” rating to a “buy” rating in a report on Wednesday, August 8th. B. Riley increased their price objective on Zumiez from $27.50 to $30.00 and gave the stock a “buy” rating in a report on Friday, June 8th. Robert W. Baird reiterated a “hold” rating and issued a $28.00 price objective on shares of Zumiez in a report on Thursday, August 9th. Finally, TheStreet cut Zumiez from a “b-” rating to a “c+” rating in a report on Monday, July 16th. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Zumiez presently has a consensus rating of “Hold” and an average price target of $27.25.

Best Heal Care Stocks To Own For 2019: Myriad Genetics, Inc.(MYGN)


Advisors’ Opinion:

  • [By Keith Speights]

    If you’re looking for stocks that have made tremendous comebacks in 2018, Opko Health (NASDAQ:OPK) and Myriad Genetics (NASDAQ:MYGN) definitely fit the bill. Opko stock was down nearly 20% this year before roaring back. Myriad Genetics saw its share price plunge close to 40% earlier in 2018, but a strong rebound has the stock price close to where it began the year. 

  • [By Stephan Byrd]

    SG Americas Securities LLC trimmed its position in Myriad Genetics, Inc. (NASDAQ:MYGN) by 45.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,704 shares of the company’s stock after selling 8,075 shares during the quarter. SG Americas Securities LLC’s holdings in Myriad Genetics were worth $363,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    DekaBank Deutsche Girozentrale lowered its holdings in Myriad Genetics (NASDAQ:MYGN) by 14.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,151 shares of the company’s stock after selling 6,642 shares during the period. DekaBank Deutsche Girozentrale owned about 0.06% of Myriad Genetics worth $1,158,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Myriad Genetics (MYGN)


    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    By submitting your email address you will receive a free subscription to Profit Alerts and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

    The Top Stock Market Stories for Tuesday
    Hedge fund manager Carl Icahn has reversed his position on a potential deal between Cigna Inc. (NYSE: CI) and Express Scripts Holding Co. (Nasdaq: ESRX). Icahn is no longer seeking votes against the $52 billion merger. Icahn had previously written a letter that argued Cigna was paying too much for the pharmacy-benefits manager. The turning point came after proxy advisories Glass Lewis & Co. and Institutional Shareholder Services Inc. both issued their public support for the deal. Hedge fund manager David Einhorn and his firm Greenlight Capital made a major announcement this morning. The fund has cut its stake in Apple Inc. (Nasdaq: AAPL), Twitter Inc. (NYSE: TWTR), and Micron Technology Inc. (Nasdaq: MU). The updates came in a filing to the U.S. Securities and Exchange Commission and stated his firm’s positions at the end of the second quarter.
    Three Stocks to Watch Today: HD, TSLA, KO
    Shares of Home Depot Inc. (NYSE: HD) are on the move after the home retail giant reported earnings before the bell. Home Depot said earnings per share came in at $3.05 on top of $30.46 billion in revenue. The average Wall Street estimate was $2.84 on top of $29.98 billion in revenue. The firm also hiked its full-year guidance. Shares of HD stock were up 2.2% in pre-market hours. Tesla Inc. (Nasdaq: TSLA) is dominating the news as CEO Elon Musk continues to push the narrative that he will be taking his company private. According to Reuters, Musk has been speaking with Saudi Arabian financiers and others about a deal to de-list Tesla. Meanwhile, Musk is facing a lawsuit from short sellers who claim that Musk’s recent announcement of his plan on Twitter last week was part of a broader

Best Heal Care Stocks To Own For 2019: Luxoft Holding, Inc.(LXFT)


Advisors’ Opinion:

  • [By Shane Hupp]

    Luxoft Holding Inc (NYSE:LXFT) has been given an average rating of “Hold” by the fourteen brokerages that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $53.33.

  • [By Steve Symington]

    Shares of Luxoft Holding Inc. (NYSE:LXFT) were down 21.3% as of 11:30 a.m. EDT Thursday after the software development company announced strong quarterly results, but followed with light guidance.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Luxoft (LXFT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Luxoft (LXFT)


    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Own For 2019: Live Nation Entertainment, Inc.(LYV)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Live Nation Entertainment (NYSE:LYV) closed 12.5% higher on Friday, following the release of strong first-quarter results. Earlier in the day, share prices jumped as much as 14.9% higher.

  • [By Anders Bylund]

    World-leading event organizer and ticker seller Live Nation Entertainment Inc. (NYSE:LYV) reported first-quarter results on Thursday. The company posted 19% top-line growth and 76% higher cash flows, and management is leaning on rock festivals and amphitheater shows to fuel further growth.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Live Nation Entertainment (LYV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    In this segment from Industry Focus: Consumer Goods, host Vincent Shen and Motley Fool contributor Nick Sciple break down Live Nation’s (NYSE:LYV) position relative to its competitors and give their final takeaways for investors looking to invest in the live events industry.

  • [By Shane Hupp]

    Live Nation Entertainment, Inc. (NYSE:LYV) President Joe Berchtold sold 40,000 shares of the business’s stock in a transaction dated Thursday, August 23rd. The stock was sold at an average price of $49.33, for a total transaction of $1,973,200.00. Following the completion of the sale, the president now owns 163,409 shares in the company, valued at $8,060,965.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Live Nation Entertainment alerts:

    International Game Technology (IGT) Ex-Dividend Date Scheduled for August 13, 2018 (nasdaq.com) Spirit Airlines, Inc. (SAVE) and Live Nation Entertainment, Inc. (LYV): Investor Checklist Stocks (talktraders.com) Hot Stock to Track – Live Nation Entertainment Inc (NYSE: LYV) (hotstockspotter.com) How many Analysts recommend Live Nation Entertainment, Inc. (LYV) to expect to do slightly better than the market … (topdesertsafari.com) Insider Selling: Live Nation Entertainment, Inc. (LYV) CFO Sells 20,000 Shares of Stock (americanbankingnews.com)


    NYSE:LYV opened at $49.20 on Friday. Live Nation Entertainment has a 52 week low of $35.94 and a 52 week high of $52.84. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 1.95. The firm has a market capitalization of $10.35 billion, a price-to-earnings ratio of -102.50 and a beta of 1.03.

Best Heal Care Stocks To Own For 2019: Costco Wholesale Corporation(COST)

Advisors’ Opinion:

  • [By Daniel B. Kline]

    When most people think of Costco (NASDAQ:COST), they picture its warehouses full of items sold in bulk alongside random clothes, the occasional 8-foot Teddy bear, and maybe rows of electronics. There’s also, of course, a large pharmacy section, select furniture, an area devoted to eyeglasses, a food court, and often a liquor store.

  • [By Chris Lange]

    Costco Wholesale Corp. (NASDAQ: COST) is scheduled to release its most recent quarterly report late Wednesday. The consensus forecast calls for $1.46 in EPS on $32.69 billion in revenue. Shares closed Friday at $189.33. The consensus target price is $209.20, and shares have changed hands between $150.00 and $199.88 in the past year.

  • [By Leo Sun]

    Kroger is struggling to stay relevant in a market filled with superstores like Walmart (NYSE:WMT), warehouse retailers like Costco (NASDAQ:COST), and e-commerce behemoths like Amazon.com (NASDAQ:AMZN), which swallowed Whole Foods last year. All that competition is lowering consumer price expectations, and the battles are now shifting toward aggressive delivery and pickup options.

  • [By Demitrios Kalogeropoulos]

    Investors had high hopes that Costco (NASDAQ:COST) would report broadly improving business trends in its fourth-quarter earnings results. The warehouse retailing giant’s stock dipped immediately following the report, but mainly because the company revealed that parts of its IT accounting infrastructure had been vulnerable to unauthorized use.

Best Heal Care Stocks To Own For 2019: Aquinox Pharmaceuticals, Inc.(AQXP)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) have received an average recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokers that have covered the stock in the last year is $25.25.

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern’s scoring:


    Get Aquinox Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Portola Pharma (NASDAQ: PTLA), Rhythm Pharmaceuticals Inc … (analystratings.com) Aquinox Pharmaceuticals, Inc. (AQXP) -Importance of Lower Price to Sales Ratio (P/S) (topdesertsafari.com) Aquinox Pharmaceuticals (AQXP) Issues Quarterly Earnings Results (americanbankingnews.com) Aquinox Pharmaceuticals Announces Second Quarter 2018 Financial Results (finance.yahoo.com) Aquinox: 2Q Earnings Snapshot (finance.yahoo.com)


    A number of equities research analysts have recently issued reports on AQXP shares. BidaskClub upgraded Aquinox Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Needham & Company LLC reiterated a “buy” rating and issued a $25.00 target price on shares of Aquinox Pharmaceuticals in a research note on Tuesday, May 8th. Zacks Investment Research upgraded Aquinox Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Tuesday, May 15th. ValuEngine upgraded Aquinox Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, June 1st. Finally, Cantor Fitzgerald reiterated a “neutral” rating on shares of Aquinox Pharmaceuticals in a research note on Wednesday, June 27th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $20.80.

  • [By Logan Wallace]

    Aquinox Pharmaceuticals (NASDAQ:AQXP) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a report released on Monday.

  • [By Ethan Ryder]

    Cantor Fitzgerald reiterated their neutral rating on shares of Aquinox Pharmaceuticals (NASDAQ:AQXP) in a research report report published on Wednesday, MarketBeat.com reports.

  • [By Steve Symington]

    Still, some individual companies fared worse than most. Read on to learn why Sonic Corporation (NASDAQ:SONC), National Beverage (NASDAQ:FIZZ), and Aquinox Pharmaceuticals (NASDAQ:AQXP) plunged today.

  • [By Paul Ausick]

    Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) dropped about nearly 85% Wednesday to post a new 52-week low of $2.25. Shares closed at $15.31 on Tuesday and the stock’s 52-week high is $16.90. Volume totaled 13.5 million shares compared to a daily average of less than 200,000. The company’s bladder pain drug failed a trial and the company is stopping development.

Best Heal Care Stocks To Own For 2019: Long Island Iced Tea Corp. (LTEA)

Advisors’ Opinion:

  • [By ]

    Long Island Ice Tea changed its name to Long Blockchain (Nasdaq: LTEA), sending shares 200% higher. It remains to be seen how a beverage maker will create shareholder value from blockchain technology — not that its investors care. 

  • [By ]

    5. Blockchain-Related Stocks
    Shorting blockchain-related stocks is an ideal way to not only short bitcoin but also short the entire cryptocurrency craze. Many such stocks exist, such as Riot Blockchain (Nasdaq: RIOT), Long Blockchain (Nasdaq: LTEA), and Longfin (Nasdaq: LFIN). Choose the one that you think is most overhyped and short away!

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

Leave a Reply

Your email address will not be published.